(Press-News.org) A low intake of folate and vitamin B12 increases the risk of melancholic depressive symptoms, according to a study among nearly 3,000 middle-aged and elderly Finnish subjects. On the other hand, non-melancholic depressive symptoms are associated with an increased risk for the metabolic syndrome. Based on these new observations, melancholic and non-melancholic depression may be separate depressive subtypes with different etiologies in terms of proinflammation and diet. The study was the first to look at these depressive sub-types separately.
"The findings have practical implications in the care of patients with depressive symptoms. For example, it may be wise to avoid medication causing weight gain among patients with non-melancholic depression, whereas melancholic depressive symptoms may call for a closer look at the quality of the patient's diet," says Mr Jussi Seppälä, MD, Chief of the Department of Psychiatry of the Hospital District of Southern Savo.
Melancholic depression involves typical depressive symptoms, such as a depressed mood. Non-melancholic depression is characterized by other types of symptoms, such as low self-esteem and feelings of worry and anxiety.
Among subjects with the highest folate intake, the risk for melancholic depressive symptoms was almost 50 per cent lower than among those with the lowest intake. In addition, among those with the highest vitamin B12 levels, the risk for melancholic depressive symptoms was almost three times lower than among those with the lowest levels. Both findings are new. A similar association with non-melancholic depressive symptoms was not observed.
Another novel observation is that the risk for the metabolic syndrome was twofold among those with non-melancholic depressive symptoms, as compared to those with melancholic symptoms or those with no depressive symptoms.
Mr Seppälä's doctoral thesis "Depressive symptoms, metabolic syndrome and diet" was published at the University of Eastern Finland. The study was conducted as part of the Finnish Type 2 Diabetes Prevention Programme. The findings were originally published in Journal of Affective Disorders.
###
To see the original press release in Finnish, click here. END
Lack of nutrients and metabolic syndrome linked to different subtypes of depression
2012-11-26
ELSE PRESS RELEASES FROM THIS DATE:
More Facebook friends means more stress, says report
2012-11-26
A large number of friends on Facebook may appear impressive but, according to a new report, the more social circles a person is linked to online the more likely social media will be a source of stress.
A report from the University of Edinburgh Business School has found that the more groups of people in someone's Facebook friends, the greater potential to cause offence. In particular, adding employers or parents resulted in the greatest increase in anxiety.
Stress arises when a user presents a version of themself on Facebook that is unacceptable to some of their online ...
Crash landings
2012-11-26
Diagnosing an injury in a swan is a far from easy undertaking. Not only are swans large, frequently weighing over 10 kg, but they are generally not happy at being handled and thus many of them can only be examined after sedation, which naturally represents a risk. The hip joints of many species of bird are known to be vulnerable to injury but swans are believed to suffer broken hips only rarely. The traditional way of examining the birds' hips relies on radiography but Gumpenberger and Scope now show that computerized tomography (CT) gives more reliable findings.
The ...
Release all Tamiflu data as promised, argue researchers
2012-11-26
The latest correspondence is posted online today as part of the BMJ's open data campaign, aimed at persuading Roche to honour the promise it made almost three years ago to make key Tamiflu trial data available for independent scrutiny.
Last week, Donald MacLean, Life Cycle Leader for Tamiflu, wrote to Professor Chris Del Mar in his capacity as coordinating editor of the Cochrane Acute Respiratory Infections Group, concerning "our debate on Tamiflu data."
The Cochrane researchers say they object to Roche's suggestion that there is a debate on Tamiflu data. "There is ...
How does a volcanic crater grow? Grab some TNT and find out
2012-11-26
BUFFALO, N.Y. -- A new University at Buffalo study in the journal Geophysical Research Letters examines maar craters, which resemble the bowl-like cavities formed by meteorites but are in some ways more mysterious.
Scientists often can discern pertinent details about meteorites -- when they struck, how large they were, the angle they approached Earth and other information -- by measuring the diameter and volume of the impact crater.
Maar craters, which form when fissures of magma beneath Earth's surface meet groundwater, causing volcanic explosions, are not as telling, ...
BioMAP screening procedure could streamline search for new antibiotics
2012-11-26
Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources.
Public health officials warn of a looming antibiotic crisis due to the steady increase in antibiotic resistance and a dramatic decline in the development of new antibiotics. Most currently available antibiotics are derived from natural compounds produced by microorganisms such as bacteria and fungi. New antibiotics developed by drug companies are ...
New device hides, on cue, from infrared cameras
2012-11-26
Cambridge, Mass. - November 26, 2012 - Now you see it, now you don't.
A new device invented at the Harvard School of Engineering and Applied Sciences (SEAS) can absorb 99.75% of infrared light that shines on it. When activated, it appears black to infrared cameras.
Composed of just a 180-nanometer-thick layer of vanadium dioxide (VO2) on top of a sheet of sapphire, the device reacts to temperature changes by reflecting dramatically more or less infrared light.
Announced today in the journal Applied Physics Letters, and featured on its cover, this perfect absorber ...
Seizures linked to surgery drugs can be prevented by anesthetics, U of T team finds
2012-11-26
Two drugs commonly given during cardiac surgery can lead to convulsive seizures, but anesthetics can help cut the risk, according to new research from the Faculty of Medicine at the University of Toronto.
Patients undergoing complex heart operations or trauma surgery are often given tranexamic acid (TXA) and aminocaproic acid (EACA) to reduce blood loss. But Faculty of Medicine researchers found these drugs are associated with a four-to-six-fold increase in post-operative seizures. The risk is highest for cardiac surgery patients – between three and seven and a half per ...
Researchers test novel power system for space travel
2012-11-26
LOS ALAMOS, N.M., Nov. 26, 2012 — A team of researchers, including engineers from Los Alamos National Laboratory, has demonstrated a new concept for a reliable nuclear reactor that could be used on space flights.
The research team recently demonstrated the first use of a heat pipe to cool a small nuclear reactor and power a Stirling engine at the Nevada National Security Site's Device Assembly Facility near Las Vegas. The Demonstration Using Flattop Fissions (DUFF) experiment produced 24 watts of electricity. A team of engineers from Los Alamos, the NASA Glenn Research ...
Cyber Monday at CocktailNerd Brings the Biggest E-Cig Savings of 2012
2012-11-26
Cyber Monday is here and it brings one last chance for electronic cigarette fans to save big on all of their favorite e-cig starter kits and accessories. CocktailNerd.com is offering readers big savings on Cyber Monday with exclusive deals that will expire at midnight. This is the year's biggest sale on all of the best electronic cigarettes brands and with exclusive coupon codes from Cocktail Nerd, e-cig shoppers can save up to 65% on all of their favorite products.
Cocktail Nerd is the Internet's most cutting edge website for e-cig news, reviews, and savings. The site ...
Alzheimer's disease in mice alleviated promising therapeutic approach for humans
2012-11-26
Alzheimer's disease is one of the most common causes of dementia. In Germany and Switzerland alone, around 1.5 million people are affected, and forecasts predict a doubling of the number of patients worldwide within the next 20 years. The accumulation of particular abnormal proteins, including amyloid-ß (Aβ) among others, in patients' brains plays a central role in this disease. Prof. Frank Heppner from the Department of Neuropathology at Charité and his colleague Prof. Burkhard Becher from the Institute for Experimental Immunology at the University of Zurich were ...